Macrogenics (MGNX) Receivables (2012 - 2026)

Macrogenics (MGNX) has reported Receivables for 15 consecutive years, with $10.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Receivables fell 1.12% year-over-year to $10.4 million; the TTM figure through Mar 2026 stood at $10.4 million (down 1.12% YoY), while the FY2025 annual figure was $13.4 million, up 210.35% from the prior year.
• Receivables declined to $10.4 million in Q1 2026 per MGNX's latest filing, from $13.4 million in the prior quarter.
• Across five years, Receivables topped out at $69.2 million in Q3 2025 and bottomed at $4.3 million in Q4 2024.
• Historically, Receivables has averaged $19.1 million across 5 years, with a median of $12.5 million in 2025.
• Annual changes were most pronounced in 2023 — Receivables plunged 81.56% — and 2025, when it jumped 691.2%.
• Macrogenics' Receivables stood at $56.2 million in 2022, then slumped by 81.56% to $10.4 million in 2023, then tumbled by 58.44% to $4.3 million in 2024, then surged by 210.35% to $13.4 million in 2025, then decreased by 22.04% to $10.4 million in 2026.
• Business Quant data shows MGNX's Receivables at $10.4 million in Q1 2026, $13.4 million in Q4 2025, and $69.2 million in Q3 2025.